Hypera SA (HYPMY)
4.195
-0.21
(-4.77%)
USD |
OTCM |
Dec 26, 16:00
Hypera Market Cap: 2.655B for Dec. 26, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Raia Drogasil SA | 8.555B |
| CEL-SCI Corp. | 14.29M |
| AIM ImmunoTech, Inc. | 0.9553M |
| IGC Pharma, Inc. | 27.85M |
| NovaBay Pharmaceuticals, Inc. | 611.15M |
Market Cap Related Metrics
| PE Ratio | 17.98 |
| PS Ratio | 2.172 |
| Price to Book Value | 1.154 |
| Price to Free Cash Flow | 24.84 |
| Price | 4.195 |
| Earnings Yield | 5.56% |
| Operating PE Ratio | 12.90 |
| Normalized PE Ratio | 18.74 |